Immunogenic Cell Death Inducing Metal Complexes for Cancer Therapy

Area of Science:

• Oncology
• Immunology
• Materials Science

Background:

• Cancer remains a leading cause of global mortality, with metastases and tumor relapse being primary drivers of death.
• Existing treatments often fail to address secondary tumors, highlighting the need for innovative therapeutic strategies.
• Immunogenic cell death (ICD) inducing agents are emerging as promising approaches to combat cancer by triggering localized cell death and systemic immune responses.

Purpose of the Study:

• To systematically review the application of metal complexes as agents capable of inducing immunogenic cell death.
• To explore the potential of metal complexes in overcoming challenges posed by metastatic and relapsing tumors.

Main Methods:

• Literature review focusing on studies investigating metal complexes for cancer therapy.
• Analysis of research on the mechanisms of immunogenic cell death induced by metal complexes.
• Evaluation of preliminary data on the efficacy of these compounds against metastatic and relapsing cancers.

Main Results:

• Metal complexes are being investigated as potent inducers of immunogenic cell death.
• These compounds demonstrate the ability to trigger localized cancer cell death.
• Preliminary findings suggest potential efficacy against metastatic and relapsing tumors by stimulating an immune response.

Conclusions:

• Metal complexes represent a promising class of compounds for developing novel cancer immunotherapies.
• The ability of metal complexes to induce immunogenic cell death offers a potential strategy to overcome treatment-resistant cancers.
• Further research into metal-based ICD agents is warranted to develop effective treatments for metastatic and relapsing diseases.